PDF release >>
Bethesda, MD (January 9, 2012) — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium today announced the release of biomarker data from studies intended to improve our ability to diagnose and measure the progression of Alzheimer’s disease (AD). Researchers used proteomics to identify biomarkers for Alzheimer’s disease using cerebrospinal fluid (CSF) samples provided by the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the largest public-private partnership to date in AD research. As with all ADNI data, these have been made openly available to the global research community.

PDF release >>
Bethesda, MD (November 8, 2011) — The Foundation for the National Institutes of Health (FNIH) today announced U.S. Surgeon General, Regina M. Benjamin, MD, MBA, will deliver a keynote address on December 6^th, the second day of the 2011 mHealth Summit, at 9:45 a.m.

Researchers aim to advance acceptance of new biomarkers for monitoring kidney safety in the clinic
PDF release >>
Bethesda, MD (November 1, 2011) – The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a two-year clinical study aiming to advance the acceptance of new biomarkers designed to detect drug-induced kidney injury in clinical trials. The study is being conducted in collaboration with the Predictive Safety Testing Consortium (PSTC), a public-private partnership founded by the Arizona-based non-profit Critical Path Institute (C-Path).

PDF release >>
Bethesda, MD (October 10, 2011) — The Foundation for the National Institutes of Health (FNIH) today announced it will host the first U.S.–Russia Scientific Forum on November 16-18, 2011, in Moscow, Russia to facilitate broader collaboration between the two countries in the areas of biomedical and behavioral research.